
NantHealth, Inc. (NH) Stock Overview
Explore NantHealth, Inc.’s financial performance, market position, analyst ratings, and future outlook.
NantHealth, Inc. (NH)
Key Financials
Key Financials
Market Cap
0
P/E Ratio
-0.15
EPS (TTM)
$-11.40
ROE
0.35%
NH Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of NantHealth, Inc. (NASDAQ: NH) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, NantHealth, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of NH on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $N/A for the NASDAQ listing.
Key metrics behind NantHealth, Inc.'s NASDAQ-traded stock include a P/E ratio of -0.15 and a market capitalization of 0. Combined with our AI analysis, these give both institutional and retail investors a clear view of NH on the NASDAQ.